Top Markets
#1 Pleasing Gold Pleasing Gold +1,463.60%
#2 PulseChain PulseChain +59.45%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.17%
#4 BOOK OF MEME BOOK OF MEME +31.56%
#5 Ontology Gas Ontology Gas +27.50%
#6 Unit Pump Unit Pump +24.39%
#7 Pump.fun Pump.fun +24.39%
#8 Nockchain Nockchain +23.32%
#9 ConstitutionDAO ConstitutionDAO +21.69%
#10 Neiro Neiro +19.99%
Coin of the day
Pleasing Gold Pleasing Gold
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc.

ARPO
Peringkat dalam Saham #26438
Aerpio Pharmaceuticals Inc., a biopharmaceutical enterprise headquartered in... Aerpio Pharmaceuticals Inc., a biopharmaceutical enterprise headquartered in Blue Ash, Ohio, currently employs 27 full-time staff. The company's core mission revolves around the research and development of therapeutic solutions for ocular diseases. Its product pipeline is spearheaded by AKB-9778, with two additional programs, AKB-4924 and ARP-1536, also under development. AKB-9778 is a small molecule designed to activate the Tie-2 pathway, intended for the treatment of diabetic retinopathy (DR). AKB-4924, another candidate, functions as a selective stabilizer of hypoxia-inducible factor-1 alpha (HIF-1alpha) and is being investigated for its potential in treating inflammatory bowel disease (IBD). ARP-1536 is a humanized monoclonal antibody that targets the same pathway as AKB-9778. It operates by attaching to the extracellular domain of vascular endothelial protein tyrosine phosphatase (VE-PTP), thereby inhibiting its interaction with Tie-2. As of April 14, 2017, Aerpio had successfully concluded a Phase II clinical trial for AKB-9778, which involved 144 patients with diabetic macular edema. By the same date, a Phase Ia clinical trial for AKB-4924 in healthy volunteers had also been completed.
Harga Saham
$2.20
Terakhir disinkronkan: 2021-08-26
Kapitalisasi Pasar
$40.53M
Perubahan (1 hari)
-0.90%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Aerpio Pharmaceuticals, Inc. (ARPO)

Kategori

Healthcare
Riwayat dividen untuk Aerpio Pharmaceuticals, Inc. (ARPO)
Saham Aerpio Pharmaceuticals, Inc. (simbol: ARPO) telah membayar total 0 dividen.
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk Aerpio Pharmaceuticals, Inc. (ARPO) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH